Compare Carnival Corp (CCL) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Carnival Corp vs Heron Therapeutics Inc — how do they compare? Carnival Corp trades at $27.68 (market cap $39.71B), while Heron Therapeutics Inc trades at $0.32 (market cap $63.41M). The key difference: Carnival Corp is far larger — about 626.2× Heron Therapeutics Inc's market cap, and Carnival Corp pays a 1.55% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| CCL | HRTX | |
|---|---|---|
Market Cap | $39.71B | $63.41M |
Sector | Consumer Cyclical | Health |
52-Week High | $33.99 | $1.49 |
52-Week Low | $23.89 | $0.32 |
Enterprise Value | $63.63B | $161.31M |
Dividend Yield | 1.55% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.
HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Carnival Corp
Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.
Read more on CCL →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
